TRUSYNERGY

Lobbying for BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA) · Life Sciences R&D

Filing Registration

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 21, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Lobbying activity 1

Health Issues

Rare disease issues; FDA policies

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.